Main Article Content
Warfarin, Community pharmacists, Hospital pharmacists, Knowledge, Counseling, UAE
Objective: Background: Warfarin has long been regarded as the cornerstone anticoagulant for patients requiring long-term prevention or treatment of thromboembolic disorders. With adequate knowledge and counseling skills, hospital and community pharmacists can play a major role in enhancing warfarin therapy. Objective: to evaluate the knowledge and counseling practices toward warfarin among community and hospital pharmacists in UAE. Methods: A cross-sectional study involving community and hospital pharmacies was conducted with online questionnaire which was submitted to pharmacists focusing on their pharmacotherapeutic knowledge and patient education toward warfarin in UAE. Data were collected within 3 months (July, August and September 2021). SPSS Version 26 was used to analyze the data. The survey questions were sent to expert researchers in pharmacy practice for comments on their relevancy, clarity, and essentiality. Results: Among the target population sample size of 400 pharmacists were approached. Majority of the pharmacists in UAE (157/400, 39.3%) had 1-5 years of experience. Most of the participants (52%) have fair knowledge about warfarin and (62.1%) of them have fair counseling practices about warfarin. Hospital pharmacists have more knowledge than community pharmacists (Mean rank, Independent pharmacy: 166.30, Chain pharmacy: 138.01, Hospital pharmacy: 252.27, p<0.05) and they have better counseling practice than community pharmacists (Mean rank, Independent pharmacy: 188.83, Chain pharmacy: 170.18, Hospital pharmacy: 222.90, p<0.05). Conclusion: The study’s participants had moderate knowledge and counseling practices of warfarin. As a result, specialized training in warfarin therapy management for pharmacists is needed to improve therapeutic outcomes and avoid complications. Moreover, conferences or online courses should be held to train pharmacists on how to provide professional counseling to patients.
2. Ghazvinian R, Gottsäter A, Elf JL. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism. J Thromb Thrombolysis. 2018;45(2):319-324. https://doi.org/10.1007/s11239-017-1607-9
3. Mohamed AA, Alnewais ME, Ibrahim YA, et al. Pharmacists’ warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study. J Pharm Bioallied Sci. 2020;12(3):289. https://doi.org/10.4103/jpbs. JPBS_233_19
4. Vranckx P, Valgimigli M, Heidbuchel H. The Significance of drug—Drug and drug—Food interactions of oral anticoagulation.
Arrhythmia Electrophysiology Review. 2018;7(1):55. https://doi.org/10.15420/aer.2017.50.1
5. Tan CS, Lee SW. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br J Clin Pharmacol.2021;87(2):352-74. https://doi.org/10.1111/bcp.14404
6. Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice. A Reportto the US Surgeon General. Office of the Chief Pharmacist. US Public Health Service. 2011;44.
7. Mekonnen AB, McLachlan AJ, Jo-anne EB. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ open. 2016;6(2):e010003. https://doi.org/10.1136/bmjopen-2015-010003
8. İzzettin F, Celik S, Acar R, et al. The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment. Marmara Pharm J. 2019;23(6):1157-1163. https://doi.org/10.35333/jrp.2019.81
9. Al Mazrouei N, Ibrahim RM, Al Meslamani AZ, et al. The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. Int J Pharm Pract. 2021;29(2):137-44. https://doi.org/10.1093/ijpp/riaa003
10. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37-46.https://doi.org/10.2147/IPRP.S108047
11. Tahaineh L, Ali T. Community pharmacists’ knowledge of direct oral anticoagulants and warfarin in the North of Jordan: a cross sectional study. European Review for Medical and Pharmacological Sciences. 2022;26(4):1215-23. https://doi.org/10.26355/eurrev_202202_28113
12. Zahreddine L, Hallit S, Shakaroun S, et al. Knowledge of pharmacists and parents towards antibiotic use in pediatrics:a cross-sectional study in Lebanon. Pharmacy Practice (Granada). 2018 Sep;16(3):1194. https://doi.org/10.18549/PharmPract.2018.03.1194
13. Gelayee D, Mekonnen G, Atnafe S, et al. Herbal medicines: personal use, knowledge, attitude, dispensing practice, and the mbarriers among community pharmacists in Gondar, Northwest Ethiopia. Evidence-Based Complementary and Alternative Medicine. 2017;2017:6480142. https://doi.org/10.1155/2017/6480142
14. El-Bardissy A, Elewa H, Khalil A, et al. Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar. Clin Appl Thromb Hemost. 2020;26:1076029620933946. https://doi.org/10.1177/1076029620933946
15. Eljilany I, El-Bardissy A, Nemir A, et al. Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey. J Thromb Thrombolysis. 2020 Nov;50(4):957-68. https://doi.org/10.1007/s11239-020-02111-w
16. Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. World Health. 2006;9(2):149-157.
17. Albekairy AM. Pharmacists’ perceived barriers to patient counseling. J Appl Pharm Sci. 2014;4(1):70-73.
18. Choumane NS, Malaeb DN, Malaeb B, et al. A multicenter, prospective study evaluating the impact of the clinical pharmacistphysician counselling on warfarin therapy management in Lebanon. BMC Health Serv Res. 2018;18(1):1-7. https://doi.org/10.1186/s12913-018-2874-7
19. Al-Arifi MN, Wajid S, Al-Manie NK, et al. Evaluation of knowledge of Health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia. Pak J Med Sci. 2016;32(1):229. https://doi.org/10.12669/pjms.321.8902
20. Ali AA, Abdallah AA. Evaluation of attitudes of the community pharmacists toward warfarin interactions.
21. Alsaid AM, Mohamed MS, Mallhi TH, et al. Knowledge, Attitude and Practice of Community Pharmacists towards Food-Drug Interactions; A Prospective Cross-Sectional Analysis from Sudan. Latin American Journal of Pharmacy. 2022;41(3):506-14.https://doi.org/10.23880/oajmb-16000211
22. O’Bryant CL. Community pharmacists’ knowledge of and attitudes toward oral chemotherapy. J Am Pharm Assoc (Wash).
23. Boddy C. Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci. 2001;23(1):31-5. https://doi.org/10.1023/a:1011289304437
24. Showande SJ, Orok EN. Impact of pharmacists’ training on oral anticoagulant counseling: a randomized controlled trial. Patient Education and Counseling. 2021;104(5):1253-9. https://doi.org/10.1016/j.pec.2020.09.018